Role of Cardiolipin in Mitochondrial Function and Dynamics in Health and Disease: Molecular and Pharmacological Aspects

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2019 Jul 19

PMID 31315173

Citations 179

Authors

Giuseppe Paradies

Valeria Paradies

Francesca M Ruggiero

Giuseppe Petrosillo

Affiliations

Soon will be listed here.

Abstract

In eukaryotic cells, mitochondria are involved in a large array of metabolic and bioenergetic processes that are vital for cell survival. Phospholipids are the main building blocks of mitochondrial membranes. Cardiolipin (CL) is a unique phospholipid which is localized and synthesized in the inner mitochondrial membrane (IMM). It is now widely accepted that CL plays a central role in many reactions and processes involved in mitochondrial function and dynamics. Cardiolipin interacts with and is required for optimal activity of several IMM proteins, including the enzyme complexes of the electron transport chain (ETC) and ATP production and for their organization into supercomplexes. Moreover, CL plays an important role in mitochondrial membrane morphology, stability and dynamics, in mitochondrial biogenesis and protein import, in mitophagy, and in different mitochondrial steps of the apoptotic process. It is conceivable that abnormalities in CL content, composition and level of oxidation may negatively impact mitochondrial function and dynamics, with important implications in a variety of pathophysiological situations and diseases. In this review, we focus on the role played by CL in mitochondrial function and dynamics in health and diseases and on the potential of pharmacological modulation of CL through several agents in attenuating mitochondrial dysfunction.

Citing Articles

Alteration of mitochondrial function in arthropods during arboviruses infection: a review of the literature.

Santana-Roman M, Ramirez-Carreto S, Maycotte P, Pando-Robles V Front Physiol. 2025; 16:1507059.

PMID: 40017802 PMC: 11865064. DOI: 10.3389/fphys.2025.1507059.

Total cardiolipin levels in gastric and colon cancer: evaluating the prognostic potential.

Dimitrijevs P, Freiliba I, Pcolkins A, Leja M, Arsenyan P Lipids Health Dis. 2025; 24(1):76.

PMID: 40016755 PMC: 11866619. DOI: 10.1186/s12944-025-02499-5.

Multi-tissue metabolomics reveal mtDNA- and diet-specific metabolite profiles in a mouse model of cardiometabolic disease.

Shastry A, Wilkinson M, Miller D, Kuriakose M, Veeneman J, Smith M Redox Biol. 2025; 81:103541.

PMID: 39983345 PMC: 11893332. DOI: 10.1016/j.redox.2025.103541.

Tafazzin regulates neutrophil maturation and inflammatory response.

Zakrzewski P, Rice C, Fleming K, Cela D, Groves S, Ponce-Garcia F EMBO Rep. 2025; .

PMID: 39962231 DOI: 10.1038/s44319-025-00393-w.

Epstein-Barr virus-driven cardiolipin synthesis sustains metabolic remodeling during B cell transformation.

You H, Havey L, Li Z, Wang Y, Asara J, Guo R Sci Adv. 2025; 11(5):eadr8837.

PMID: 39879311 PMC: 11777256. DOI: 10.1126/sciadv.adr8837.

References

Kagan V, Tyurin V, Jiang J, Tyurina Y, Ritov V, Amoscato A . Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol. 2006; 1(4):223-32. DOI: 10.1038/nchembio727. View

Letts J, Sazanov L . Clarifying the supercomplex: the higher-order organization of the mitochondrial electron transport chain. Nat Struct Mol Biol. 2017; 24(10):800-808. DOI: 10.1038/nsmb.3460. View

Lu Y, Claypool S . Disorders of phospholipid metabolism: an emerging class of mitochondrial disease due to defects in nuclear genes. Front Genet. 2015; 6:3. PMC: 4315098. DOI: 10.3389/fgene.2015.00003. View

Consolini A, Ragone M, Bonazzola P, Colareda G . Mitochondrial Bioenergetics During Ischemia and Reperfusion. Adv Exp Med Biol. 2017; 982:141-167. DOI: 10.1007/978-3-319-55330-6_8. View

Perier C, Tieu K, Guegan C, Caspersen C, Jackson-Lewis V, Carelli V . Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage. Proc Natl Acad Sci U S A. 2005; 102(52):19126-31. PMC: 1323177. DOI: 10.1073/pnas.0508215102. View

Paradies G, Petrosillo G, Pistolese M, Di Venosa N, Serena D, Ruggiero F . Lipid peroxidation and alterations to oxidative metabolism in mitochondria isolated from rat heart subjected to ischemia and reperfusion. Free Radic Biol Med. 1999; 27(1-2):42-50. DOI: 10.1016/s0891-5849(99)00032-5. View

Paradies G, Petrosillo G, Pistolese M, Ruggiero F . Reactive oxygen species affect mitochondrial electron transport complex I activity through oxidative cardiolipin damage. Gene. 2002; 286(1):135-41. DOI: 10.1016/s0378-1119(01)00814-9. View

Huang Y, Powers C, Madala S, Greis K, Haffey W, Towbin J . Cardiac metabolic pathways affected in the mouse model of barth syndrome. PLoS One. 2015; 10(6):e0128561. PMC: 4451073. DOI: 10.1371/journal.pone.0128561. View

Klingenberg M . Cardiolipin and mitochondrial carriers. Biochim Biophys Acta. 2009; 1788(10):2048-58. DOI: 10.1016/j.bbamem.2009.06.007. View

10.

Claypool S, Oktay Y, Boontheung P, Loo J, Koehler C . Cardiolipin defines the interactome of the major ADP/ATP carrier protein of the mitochondrial inner membrane. J Cell Biol. 2008; 182(5):937-50. PMC: 2528576. DOI: 10.1083/jcb.200801152. View

11.

Dudek J, Hartmann M, Rehling P . The role of mitochondrial cardiolipin in heart function and its implication in cardiac disease. Biochim Biophys Acta Mol Basis Dis. 2019; 1865(4):810-821. DOI: 10.1016/j.bbadis.2018.08.025. View

12.

Lucken-Ardjomande S, Montessuit S, Martinou J . Contributions to Bax insertion and oligomerization of lipids of the mitochondrial outer membrane. Cell Death Differ. 2008; 15(5):929-37. DOI: 10.1038/cdd.2008.9. View

13.

Mileykovskaya E, Dowhan W . Cardiolipin-dependent formation of mitochondrial respiratory supercomplexes. Chem Phys Lipids. 2013; 179:42-8. PMC: 3947694. DOI: 10.1016/j.chemphyslip.2013.10.012. View

14.

Giorgio V, von Stockum S, Antoniel M, Fabbro A, Fogolari F, Forte M . Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc Natl Acad Sci U S A. 2013; 110(15):5887-92. PMC: 3625323. DOI: 10.1073/pnas.1217823110. View

15.

Tan D, Manchester L, Qin L, Reiter R . Melatonin: A Mitochondrial Targeting Molecule Involving Mitochondrial Protection and Dynamics. Int J Mol Sci. 2016; 17(12). PMC: 5187924. DOI: 10.3390/ijms17122124. View

16.

Petrosillo G, Moro N, Ruggiero F, Paradies G . Melatonin inhibits cardiolipin peroxidation in mitochondria and prevents the mitochondrial permeability transition and cytochrome c release. Free Radic Biol Med. 2009; 47(7):969-74. DOI: 10.1016/j.freeradbiomed.2009.06.032. View

17.

Palmieri F, Pierri C . Mitochondrial metabolite transport. Essays Biochem. 2010; 47:37-52. DOI: 10.1042/bse0470037. View

18.

Clarke S, Bowron A, Gonzalez I, Groves S, Newbury-Ecob R, Clayton N . Barth syndrome. Orphanet J Rare Dis. 2013; 8:23. PMC: 3583704. DOI: 10.1186/1750-1172-8-23. View

19.

Karch J, Molkentin J . Identifying the components of the elusive mitochondrial permeability transition pore. Proc Natl Acad Sci U S A. 2014; 111(29):10396-7. PMC: 4115577. DOI: 10.1073/pnas.1410104111. View

20.

Ma Z, Zhao Z, Turk J . Mitochondrial dysfunction and β-cell failure in type 2 diabetes mellitus. Exp Diabetes Res. 2011; 2012:703538. PMC: 3216264. DOI: 10.1155/2012/703538. View